4.8 Article

VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells

期刊

NATURE CELL BIOLOGY
卷 24, 期 3, 页码 290-+

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41556-022-00849-4

关键词

-

向作者/读者索取更多资源

VCAM1 not only exists on healthy HSCs, but is also upregulated on leukaemic stem cells (LSCs), where it plays a 'don't-eat-me' role through interaction with MHC-I presentation, ensuring the integrity of HSCs when entering the bone marrow. The 'don't-eat-me' activity of VCAM1 is regulated by beta 2-microglobulin MHC presentation on HSCs and paired Ig-like receptor-B (PIR-B) on phagocytes. Additionally, VCAM1 is upregulated in cancer cells, providing an avenue for cancer cells to escape immune detection.
Haematopoietic stem cells (HSCs) home to the bone marrow via, in part, interactions with vascular cell adhesion molecule-1 (VCAM1)(1-3). Once in the bone marrow, HSCs are vetted by perivascular phagocytes to ensure their self-integrity. Here we show that VCAM1 is also expressed on healthy HSCs and upregulated on leukaemic stem cells (LSCs), where it serves as a quality-control checkpoint for entry into bone marrow by providing 'don't-eat-me' stamping in the context of major histocompatibility complex class-I (MHC-I) presentation. Although haplotype-mismatched HSCs can engraft, Vcam1 deletion, in the setting of haplotype mismatch, leads to impaired haematopoietic recovery due to HSC clearance by mononuclear phagocytes. Mechanistically, VCAM1 'don't-eat-me' activity is regulated by beta 2-microglobulin MHC presentation on HSCs and paired Ig-like receptor-B (PIR-B) on phagocytes. VCAM1 is also used by cancer cells to escape immune detection as its expression is upregulated in multiple cancers, including acute myeloid leukaemia (AML), where high expression associates with poor prognosis. In AML, VCAM1 promotes disease progression, whereas VCAM1 inhibition or deletion reduces leukaemia burden and extends survival. These results suggest that VCAM1 engagement regulates a critical immune-checkpoint gate in the bone marrow, and offers an alternative strategy to eliminate cancer cells via modulation of the innate immune tolerance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据